A detailed history of Kestra Private Wealth Services, LLC transactions in Organon & Co. stock. As of the latest transaction made, Kestra Private Wealth Services, LLC holds 19,907 shares of OGN stock, worth $293,230. This represents 0.01% of its overall portfolio holdings.

Number of Shares
19,907
Previous 20,899 4.75%
Holding current value
$293,230
Previous $432,000 12.04%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$18.65 - $23.03 $18,500 - $22,845
-992 Reduced 4.75%
19,907 $380,000
Q2 2024

Aug 12, 2024

SELL
$17.45 - $21.96 $15,233 - $19,171
-873 Reduced 4.01%
20,899 $432,000
Q1 2024

May 02, 2024

BUY
$13.78 - $18.8 $7,661 - $10,452
556 Added 2.62%
21,772 $409,000
Q4 2023

Feb 05, 2024

BUY
$10.95 - $17.32 $16,676 - $26,378
1,523 Added 7.73%
21,216 $305,000
Q3 2023

Nov 07, 2023

BUY
$16.59 - $23.77 $40,164 - $57,547
2,421 Added 14.02%
19,693 $341,000
Q2 2023

Aug 08, 2023

SELL
$19.27 - $24.63 $56,981 - $72,830
-2,957 Reduced 14.62%
17,272 $359,000
Q1 2023

May 12, 2023

SELL
$21.42 - $32.08 $5,397 - $8,084
-252 Reduced 1.23%
20,229 $475,000
Q4 2022

Jan 31, 2023

SELL
$23.31 - $28.61 $56,969 - $69,922
-2,444 Reduced 10.66%
20,481 $572,000
Q3 2022

Nov 14, 2022

BUY
$23.4 - $34.25 $213,291 - $312,188
9,115 Added 66.0%
22,925 $536,000
Q2 2022

Aug 12, 2022

SELL
$31.66 - $38.9 $7,946 - $9,763
-251 Reduced 1.79%
13,810 $466,000
Q1 2022

May 26, 2022

SELL
$30.45 - $39.36 $11,357 - $14,681
-373 Reduced 2.58%
14,061 $491,000
Q4 2021

Jan 21, 2022

BUY
$28.67 - $37.13 $221,303 - $286,606
7,719 Added 114.95%
14,434 $439,000
Q3 2021

Oct 21, 2021

SELL
$28.63 - $35.64 $43,889 - $54,636
-1,533 Reduced 18.59%
6,715 $220,000
Q2 2021

Jul 30, 2021

BUY
$28.45 - $38.0 $234,655 - $313,424
8,248 New
8,248 $249,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Kestra Private Wealth Services, LLC Portfolio

Follow Kestra Private Wealth Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Private Wealth Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Private Wealth Services, LLC with notifications on news.